stock & financial message boards
  Joined Today: 2

  Login  |  Registration |  Site Map  |  Stock Market Blogs reaching thousands of users every day  |  Recent Activity  |    |

ISPH Inspire Pharmaceuticals, Stock Message Board

All Messages

ISPH Message Board Home | Join The ISPH Group | 

Page [1 of 4] < Prev
|1|2|3|4
|Next >
#46: Inspire Announces Webcast of Presentation at UBS Conference
TheMachine
September 20, 2008 02:21:23 AM
Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today that Thomas R. Staab, II, CFO and Treasurer, will present at the UBS Global Life Sciences Conference on...
view message
ignore post
recommend post
#45: Inspire Announces Plans for Clinical Testing of New Compound INS117548 for the Treatment of Glaucoma
TheMachine
September 20, 2008 02:20:59 AM
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that the standard 30-day review period by the U.S. Food and Drug Administration (FDA) relating to Inspire’s...
view message
ignore post
recommend post
#44: Re: Inspire Initiates Phase 3 Trial of Epinastine Nasal Spray for Allergic Rhinitis
FastFun
November 30, 2007 11:44:40 AM
Phase 3!  How long is phase 3 last?
view message
view parent message
ignore post
recommend post
#43: Inspire Initiates Phase 3 Trial of Epinastine Nasal Spray for Allergic Rhinitis
FastFun
November 30, 2007 11:42:36 AM
  Top-line Results Expected Second Quarter 2008 Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the initiation of a Phase 3 clinical trial to evaluate epinastine nasal spray...
view message
ignore post
recommend post
#42: Inspire Announces Oral Presentation of Phase 2 Epinastine Nasal Spray Data at American College of Allergy, Asthma & Immunology Meeting
FastFun
November 27, 2007 09:11:59 PM
Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today that a presentation of its Phase 2 clinical trial data on epinastine nasal spray for the treatment of allergic rhinitis will be given...
view message
ignore post
recommend post
#41: ISPH News Inspire Announces Webcast of Presentation at Cowen and Company's 27th Annual Health Care Conference
NewsBot
March 6, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO, will present at Cowen and Company’s...
view message
ignore post
recommend post
#40: ISPH News Inspire Reports Fourth Quarter and Full Year 2006 Financial Results
NewsBot
February 27, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today financial results for the fourth quarter and year ended December 31, 2006, reporting a net...
view message
ignore post
recommend post
#39: ISPH News Inspire to Present Data at 2007 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
NewsBot
February 23, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Inspire scientists and collaborators will present information at the 2007 American...
view message
ignore post
recommend post
#38: ISPH News Inspire Announces Webcast of Presentation at Susquehanna Healthcare Conference
NewsBot
February 22, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Thomas R. Staab, II, Chief Financial Officer and Treasurer, and Donald J. Kellerman,...
view message
ignore post
recommend post
#36: ISPH News Inspire Announces Executive Management Promotions
NewsBot
February 20, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the following executive management promotions. Benjamin R. Yerxa, Ph.D. has been...
view message
ignore post
recommend post
#37: ISPH News Inspire Announces Executive Management Promotions
NewsBot
February 20, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the following executive management promotions. Benjamin R. Yerxa, Ph.D. has been...
view message
ignore post
recommend post
#35: ISPH News Inspire Licenses AzaSite(TM) For Ocular Infections
NewsBot
February 16, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the signing of an exclusive licensing agreement with InSite Vision Incorporated (AMEX: ISV)...
view message
ignore post
recommend post
#34: ISPH News Inspire Director Alan F. Holmer Resigns Board Position to Accept Senior Post in Bush Administration
NewsBot
February 13, 2007 01:30:00 PM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Alan F. Holmer has resigned from the Board of Directors of Inspire Pharmaceuticals,...
view message
ignore post
recommend post
#33: ISPH News Inspire Announces Date for Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2006 Financial Results
NewsBot
February 13, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that it plans to report fourth quarter and full year 2006 financial results on Tuesday,...
view message
ignore post
recommend post
#32: ISPH News Inspire Provides Cystic Fibrosis Clinical Program Update
NewsBot
January 16, 2007 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today announced an update on its clinical development program for denufosol tetrasodium for the treatment...
view message
ignore post
recommend post
Page [1 of 4] < Prev
|1|2|3|4
|Next >

Group Home | Login if you want to post a message